21P:FRA
Aurora Cannabis
4,62 €
arrow_downward
-0,43%(-0,020) 1 d
4 nov, 21:07:26 GMT+1 · EUR
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de 21P...
Abrir
4,49 €
Alto
4,66 €
Bajo
4,49 €
Cap. burs.
470,43 M
Vol. medio
4,10 mil
Volumen
2,83 mil
Máximo en 52 sem.
5,39 €
Mínimo en 52 sem.
2,22 €
N.º de empleados
1 mil
Abrir
4,49 €
Alto
4,66 €
Bajo
4,49 €
Cap. burs.
470,43 M
Vol. medio
4,10 mil
Volumen
2,83 mil
Máximo en 52 sem.
5,39 €
Mínimo en 52 sem.
2,22 €
N.º de empleados
1 mil
Noticias
De fuentes web y partners de noticias
TradingView
·
hace 7 horas
Aurora Cannabis Stock: What Organigram's Buyout Means for Investors
kalkine.ca
·
hace 12 horas
Aurora Cannabis Inc. Shares Advance 22.41% as Investors Reassess Growth Potential
Investing.com
·
hace 13 horas
TD Cowen downgrades Aurora Cannabis stock rating on Organigram deal
Barron's
·
hace 20 horas
Organigram Agrees to Buy Aurora Cannabis, Topping Curaleaf Bid
Perfil
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB.
After significant expansion in 2018, the company reduced expenses in the second half of 2019 when the Canadian recreational cannabis market had low sales due to excessive inventory and uncompetitive pricing with the black market. In February 2020, cofounder and chief executive, Terry Booth, resigned, being replaced by Executive Chairman Michael Singer as interim CEO. Wikipedia
Acerca de Aurora Cannabis